Six Independent Research Programs Converge on the Neuronal IRS-1 Ser307/Ser312 Inhibitory Phosphorylation Cluster as a Metabolic Route to Alzheimer's Tau Pathology

Six independent research programs studying dietary fat physiology, neuropeptide signaling, adipokine-driven neuroinflammation, tanycyte gating biology, chemokine neuroimmune crosstalk, and stress kinase signaling have converged on a common molecular node: impaired IRS-1/PI3K coupling, primarily through inhibitory phosphorylation of insulin receptor substrate-1 (IRS-1) at the Ser307/Ser312 cluster (human; rodent Ser302/Ser307), demonstrated in hypothalamic arcuate nucleus neurons and proposed to reach cortical and hippocampal neurons through the conserved inflammatory kinases JNK and IKKbeta, which are broadly expressed in those regions. On this account, phosphorylation within this IRS-1 inhibitory cluster blocks PI3K/AKT signaling, disinhibiting glycogen synthase kinase-3 beta (GSK-3beta), which hyperphosphorylates tau. This paper presents the convergence as a mechanistic hypothesis with eight falsifiable predictions, situated within the established epidemiological observation that type 2 diabetes mellitus approximately doubles the risk of late-onset Alzheimer's disease (Ott et al., 1999), a relationship for which no molecularly specific, anatomically localized account has been available. IRS-1 serine phosphorylation is specifically elevated across Alzheimer's disease, Pick's disease, corticobasal degeneration, and progressive supranuclear palsy in 157 human autopsy brains, while remaining normal in alpha-synucleinopathies and TDP-43 proteinopathies. Neuronal-enriched extracellular vesicles from plasma in the Baltimore Longitudinal Study of Aging show elevated pSer312-IRS-1 about 3.5 years before clinical AD onset in cognitively normal participants (Kapogiannis et al., 2019). Functional MRI demonstrates that type 2 diabetic patients show the predicted hypothalamic signaling failure, which normalizes within four days of dietary intervention (Teeuwisse et al., 2012). As mechanistic proof of concept, intranasal insulin augments hypothalamic BOLD responses to glucose in healthy subjects. A common IRS-1 polymorphism (Gly972Arg) produces genetically determined cerebrocortical insulin resistance in metabolically matched human subjects. **Keywords:** Alzheimer's disease; type 2 diabetes mellitus; brain insulin resistance; IRS-1 Ser307/Ser312 cluster; convergent pathway hypothesis; two-barrier model; GSK-3beta; tau hyperphosphorylation; PKC-theta; NPFFR2; TLR4; tanycyte; JNK1; HPA axis; palmitic acid; O-GlcNAcylation; entorhinal cortex; arcuate nucleus; neuronal extracellular vesicles; L1CAM; Mendelian randomization; prospective biomarker